XOOMAR

CUMBERLAND PHARMACEUTICALS INC (CPIX)

Every FINRA and SEC series the site collects for CUMBERLAND PHARMACEUTICALS INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

326K

Short interest

settlement 2026-08-14

2.7

Days to cover

-15.6% vs prior

79.8%

Short share of volume

2026-09-11

1,749

Fails to deliver

settlement 2026-08-04

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in CPIX is 326,215 shares, down 46,512 shares over the last month. Over the last 48 readings it ranged from 6,441 shares (15 July 2025) to 1,468,162 shares (13 December 2024). At the reported average volume of 122K shares a day that is 2.7 days to cover.

Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/cpix" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-08-14326,215-15.6%121,6382.68
2026-07-31386,521+3.7%138,6402.79
2026-07-15372,727+53.8%93,4243.99
2026-06-30242,415-28.4%47,5875.09
2026-06-15338,806-4.5%54,1666.25
2026-05-29354,906-22.0%168,9822.10
2026-05-15454,750-13.1%179,8572.53
2026-04-30523,399+363.6%4,873,1751.00
2026-04-15112,896+2.9%42,9092.63
2026-03-31109,732-23.1%57,8961.90
2026-03-13142,752-21.0%144,9251.00
2026-02-27180,766-6.5%127,4711.42
2026-02-13193,232+153.8%222,7801.00
2026-01-3076,121-24.5%180,7441.00
2026-01-15100,832-28.3%240,2671.00
2025-12-31140,686+360.2%287,1041.00
2025-12-1530,568+24.7%182,1611.00
2025-11-2824,522-28.0%57,8271.00
2025-11-1434,075-31.5%79,7661.00
2025-10-3149,726-6.9%34,9921.42
2025-10-1553,389-2.1%29,6741.80
2025-09-3054,551+21.1%28,3321.93
2025-09-1545,028-14.8%37,6441.20
2025-08-2952,834-1.5%28,2801.87

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of CPIX volume is 79.8%, up 34.8 points over the last five sessions. Over the last 52 readings it ranged from 14.3% (17 July 2026) to 79.8% (11 September 2026). The latest reading sits at the top of that range. The latest reading is 24.2 points above the 30-session average of 55.7%, on 6K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-09-115K6K79.8%0
2026-09-104K14K29.9%39
2026-09-094K7K48.4%40
2026-09-087K12K58.4%0
2026-09-042K4K66.1%0
2026-09-034K8K45.0%0
2026-09-028K19K43.0%0
2026-09-0117K34K48.7%153
2026-08-3137K81K45.7%1,095
2026-08-2817K23K76.1%0
2026-08-2724K36K66.5%0
2026-08-2622K47K46.9%0
2026-08-2519K34K55.3%0
2026-08-246K10K64.4%0
2026-08-215K7K66.7%0
2026-08-2023K66K34.5%0
2026-08-1913K19K68.8%0
2026-08-185K9K54.3%0
2026-08-1736K67K54.1%0
2026-08-1414K30K47.8%0
2026-08-1313K40K32.8%0
2026-08-1213K20K67.1%0
2026-08-1124K37K64.7%0
2026-08-1013K17K79.2%0
2026-08-076K14K42.7%0
2026-08-0610K21K49.1%0
2026-08-0541K77K53.0%0
2026-08-0441K88K46.5%0
2026-08-03130K208K62.7%1,002
2026-07-3122K31K72.8%0

Fails to deliver

SEC, by settlement date. JSON

As of 4 August 2026, the fails-to-deliver balance in CPIX is 1,749 shares, up 394 shares over the last settlement date. Over the last 39 readings it ranged from 1 share (30 June 2026) to 42,554 shares (24 April 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-08-041,749$7.18$13K
2026-07-301,355$6.66$9K
2026-07-2421$6.99$147
2026-07-209,500$6.84$65K
2026-07-142,603$6.54$17K
2026-07-021,351$7.13$10K
2026-06-301$6.84$7
2026-06-2218,500$5.72$106K
2026-06-05172$5.84$1K
2026-06-04172$5.61$965
2026-06-021,608$5.70$9K
2026-04-3044$4.21$185
2026-04-28377$4.19$2K
2026-04-271,208$4.06$5K
2026-04-2442,554$3.90$166K
2026-04-231,232$3.05$4K
2026-04-09200$3.14$628
2026-02-274$4.48$18
2026-02-268,256$4.10$34K
2026-02-067,463$3.59$27K
2026-02-056,696$3.94$26K
2026-01-211,294$4.72$6K
2026-01-071,098$4.72$5K
2026-01-061,498$4.00$6K
2025-12-221,016$4.41$4K
2025-12-193,426$4.38$15K
2025-10-306$3.25$20
2025-10-27115$3.49$401
2025-10-23270$3.46$934
2025-10-22973$3.65$4K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

No open-market insider trades were reported for CPIX in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Galante Joseph C on 2026-03-18.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-03-18Galante Joseph Cn/aGrant2K$2.80$5K64K
2026-03-18Jones Jamesn/aGrant2K$2.80$5K47K
2026-03-18Krogulski Kennethn/aGrant4K$2.80$11K302K
2026-03-18Krogulski Kennethn/aGrant2K$2.80$5K298K
2026-03-18Young Carolinen/aGrant2K$2.80$5K35K
2026-03-18Brown Martin S JRn/aGrant2K$2.80$5K10K
2026-03-16KAZIMI A JChairman and CEOTax withholding6K$3.06$18K5.7M
2025-12-31Young Carolinen/aL5$3.91$2033K
2025-12-31Jones Jamesn/aL7$3.91$2745K
2025-12-31KAZIMI A JChairman and CEOL7$3.91$275.7M
2025-12-31Krogulski Kennethn/aL62$3.91$242297K
2025-12-30Young Carolinen/aL2$3.94$833K
2025-12-30Jones Jamesn/aL8$3.94$3245K
2025-12-30KAZIMI A JChairman and CEOL8$3.94$325.7M
2025-12-30Krogulski Kennethn/aL54$3.94$213296K
2025-12-29Young Carolinen/aL2$4.01$833K
2025-12-29Jones Jamesn/aL8$4.01$3245K
2025-12-29KAZIMI A JChairman and CEOL8$4.01$325.7M
2025-12-29Krogulski Kennethn/aL54$4.01$217296K
2025-12-26Young Carolinen/aL2$4.21$833K
2025-12-26Jones Jamesn/aL8$4.21$3445K
2025-12-26KAZIMI A JChairman and CEOL8$4.21$345.7M
2025-12-26Krogulski Kennethn/aL54$4.21$227296K
2025-12-24Young Carolinen/aL2$4.26$933K
2025-12-24Jones Jamesn/aL8$4.26$3445K
2025-12-24KAZIMI A JChairman and CEOL8$4.26$345.7M
2025-12-24Krogulski Kennethn/aL54$4.26$230296K
2025-12-23Young Carolinen/aL2$4.13$833K
2025-12-23Jones Jamesn/aL8$4.13$3345K
2025-12-23KAZIMI A JChairman and CEOL8$4.13$335.7M
2025-12-23Krogulski Kennethn/aL54$4.13$223296K
2025-12-22Young Carolinen/aL2$4.32$933K
2025-12-22Jones Jamesn/aL7$4.32$3045K
2025-12-22KAZIMI A JChairman and CEOL7$4.32$305.7M
2025-12-22Krogulski Kennethn/aL50$4.32$216296K
2025-12-19Young Carolinen/aL2$4.19$833K
2025-12-19Jones Jamesn/aL8$4.19$3445K
2025-12-19KAZIMI A JChairman and CEOL8$4.19$345.7M
2025-12-19Krogulski Kennethn/aL52$4.19$218296K
2025-12-18Young Carolinen/aL3$4.19$1333K
2025-12-18Jones Jamesn/aL10$4.19$4245K
2025-12-18KAZIMI A JChairman and CEOL10$4.19$425.7M
2025-12-18Krogulski Kennethn/aL67$4.19$281296K
2025-12-17Young Carolinen/aL3$3.65$1133K
2025-12-17Jones Jamesn/aL10$3.65$3745K
2025-12-17KAZIMI A JChairman and CEOL10$3.65$375.7M
2025-12-17Krogulski Kennethn/aL67$3.65$245296K
2025-12-16Young Carolinen/aL3$3.27$1033K
2025-12-16Jones Jamesn/aL14$3.27$4645K
2025-12-16KAZIMI A JChairman and CEOL14$3.27$465.7M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

13F holders

Tracked managers holding CPIX at their latest 13F. JSON

3 of the 30 tracked managers held CPIX at their latest 13F, $3.9M in total at quarter-end prices. Renaissance Technologies is the largest at $3.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Renaissance Technologies2026-06-30478K$3.1M0.00%+8K
Citadel Advisors2026-06-3096K$625K0.00%+47K
Two Sigma Investments2026-06-3024K$155K0.00%+13K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 2026 (quarter ended 2026-06-30) CUMBERLAND PHARMACEUTICALS INC reported revenue of $8.8M, down 18.8% from the same quarter a year earlier, and net loss of $4.3M (-0.29 diluted EPS). In FY 2025 it generated $4.9M of operating cash flow and spent $263K on buybacks.

Cash
$3.9M
Equity
$17.4M
Total assets
$62.9M
Shares outstanding
14,983,107

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q2 20262026-06-30$8.8M-$4.3M-48.6%-0.29
Q1 20262026-03-31$9.1M-$3.3M-36.0%-0.22
Q4 20252025-12-31$13.7M-$1.4M-10.3%-0.09
Q3 20252025-09-30$8.3M-$1.9M-23.4%-0.13
Q2 20252025-06-30$10.8M-$741K-6.8%-0.05
Q1 20252025-03-31$11.7M$1.3M10.7%0.08
Q4 20242024-12-31$10.4M-$1.9M-18.2%-0.14
Q3 20242024-09-30$9.1M-$1.5M-17.0%-0.11

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$44.5M-$2.8M$4.9M$98K$263Kn/a
FY 20242024-12-31$37.9M-$6.5M-$612K$66K$579Kn/a
FY 20232023-12-31$39.6M-$6.3M$6.1M$281K$741Kn/a
FY 20222022-12-31$42.0M-$5.6M$8.5M$102K$1.1Mn/a
FY 20212021-12-31$35.0M-$3.5M$6.3M$104K$1.4Mn/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-05 from the cover page.

What this page is

CUMBERLAND PHARMACEUTICALS INC in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows CUMBERLAND PHARMACEUTICALS INC (CPIX), SEC CIK 1087294, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest
FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-04.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Insider trades
SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-03-18.JSON and CSV
Company record
EDGAR filing index for CIK 1087294Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as pharmaceutical preparations

Datasets

Frequently Asked Questions

How much of CPIX is sold short?
326,215 shares were held short at the 2026-08-14 settlement, 2.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is CPIX's daily short volume?
On 2026-09-11, 4,696 of the 5,881 CPIX shares reported to FINRA were sold short, 79.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does CPIX have fails to deliver?
The SEC's latest file shows 1,749 CPIX shares failed to deliver at settlement 2026-08-04. Fails are reported per settlement date and published twice a month with a lag.
Are CPIX insiders buying or selling?
No open-market insider trades were reported for CPIX in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Galante Joseph C on 2026-03-18.
What did CPIX report last quarter?
In Q2 2026 (quarter ended 2026-06-30) CUMBERLAND PHARMACEUTICALS INC reported revenue of $8.8M, down 18.8% from the same quarter a year earlier, and net loss of $4.3M (-0.29 diluted EPS). In FY 2025 it generated $4.9M of operating cash flow and spent $263K on buybacks.
Which funds hold CPIX?
3 of the 30 tracked managers held CPIX at their latest 13F, $3.9M in total at quarter-end prices. Renaissance Technologies is the largest at $3.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 0 cut.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.